Rabbit Calicivirus: 3 Strains, Vaccination And Prevention
Essential insights on Rabbit Calicivirus: symptoms, prevention strategies, and vaccination for pet owners.
Rabbit Calicivirus, commonly known as Rabbit Haemorrhagic Disease Virus (RHDV), poses a severe threat to rabbits worldwide, causing high mortality rates in infected populations. This highly contagious pathogen primarily affects European rabbits and certain hare species, leading to rapid fatalities often without prior warning signs.
Understanding the Pathogen and Its Variants
RHDV belongs to the genus Lagovirus within the Caliciviridae family, characterized by its ability to induce acute fatal hepatitis in leporids. First identified in China in 1984, it has since become endemic in numerous regions globally.
Several strains exist, including the classical RHDV1, its variant RHDV1a, and the more recent RHDV2. RHDV1 was introduced in Australia in 1996 as a biocontrol for wild rabbits, but its efficacy waned over time, prompting the release of RHDV1a in 2017. RHDV2, detected in Australia in 2015 after emerging in Europe in 2010, now dominates outbreaks, particularly in domestic rabbits. Unlike earlier strains, RHDV2 impacts younger rabbits and hares, broadening its host range among invasive species without affecting native Australian wildlife.
| Strain | First Detected | Primary Hosts | Key Notes |
|---|---|---|---|
| RHDV1 | 1996 (Australia) | Adult rabbits | Biocontrol agent; reduced effectiveness |
| RHDV1a | 2017 (Australia) | Adult rabbits | Variant to enhance RHDV1 |
| RHDV2 | 2010 (Europe), 2015 (Australia) | Rabbits, hares (incl. young) | Dominant; higher virulence |
Transmission Pathways in Rabbit Populations
The virus spreads efficiently through multiple routes, amplifying its contagious nature. Direct contact with infected rabbits or their bodily fluids—such as urine, feces, saliva, or blood—serves as the primary transmission method. Indirect spread occurs via contaminated equipment, clothing, housing, or vehicles.
Mechanical vectors like flies, birds, and humans facilitate further dissemination. The virus persists in the environment for extended periods, surviving 3-7 months under favorable conditions, and can aerosolize over short distances in moist air. Recovered rabbits may act as carriers, shedding the virus for up to four weeks post-infection.
- Direct contact: With live infected rabbits or cadavers.
- Indirect contact: Fomites including cages, feed dishes, and bedding.
- Vector-mediated: Insects and scavengers.
- Aerial: Limited short-range in humid environments.
Clinical Manifestations and Disease Progression
RHDV infection progresses rapidly, with an incubation period of 1-5 days. Many cases result in peracute death without observable symptoms, while acute forms present fever, lethargy, anorexia, and respiratory distress 12-36 hours post-fever onset.
Characteristic signs include bloody discharges from the nose, mouth, rectum, or urogenital tract, convulsions, coma, and foaming at the mouth. Subacute infections may yield milder symptoms with higher survival rates, potentially leading to immunity upon recovery. Chronic cases, though rare, involve jaundice, prolonged lethargy, and emaciation.
RHDV2 alters age susceptibility; rabbits under 4-6 weeks often show subclinical infection with classical strains, but RHDV2 causes severe disease and death in kits from 7-15 days old.
Diagnosis Methods for Veterinary Confirmation
Definitive diagnosis relies on post-mortem examination, revealing liver necrosis, disseminated intravascular coagulation, and hemorrhagic lesions in multiple organs. PCR testing detects viral RNA in tissues, blood, or feces, while serology identifies antibodies in survivors.
Antemortem diagnosis challenges arise due to rapid progression; clinical suspicion prompts supportive testing like bloodwork showing elevated liver enzymes. Differential diagnoses include pasteurellosis, myxomatosis, and encephalitozoonosis, necessitating comprehensive necropsy for accuracy.
Limited Treatment Options and Supportive Care
No specific antiviral treatments exist for RHDV, as its viral nature renders antibiotics ineffective against the pathogen itself. Supportive care focuses on fluid therapy, pain management, and nutritional support for rabbits surviving the acute phase, though prognosis remains poor with mortality rates of 50-100%.
Early isolation of suspects and euthanasia in confirmed outbreaks prevent spread. Research into antivirals continues, but vaccination remains the cornerstone of management.
Vaccination: The Primary Defense Strategy
Vaccines targeting RHDV strains provide robust protection, recommended annually or biannually in high-risk areas. In the US, as of 2023, outbreaks in over 32 states underscore vaccination urgency for pet rabbits.
Australia mandates vaccination for domestic rabbits against RHDV1 and RHDV2, with boosters tailored to local prevalence. Pups can receive initial doses from 4-6 weeks, depending on strain coverage. Combining with myxomatosis vaccines enhances comprehensive immunity.
Biosecurity Protocols for Rabbit Owners
Preventive measures mitigate risk effectively. Quarantine new rabbits for 30 days, implement strict hygiene with disinfectants effective against caliciviruses (e.g., 1:10 bleach solution), and use insect-proof enclosures.
- Disinfect housing weekly with approved agents.
- Avoid contact with wild rabbits or multi-rabbit events without prior vaccination.
- Secure fly screens and footbaths at entry points.
- Monitor for early signs like lethargy or nasal discharge.
Global Incidence and Regional Outbreaks
RHDV endemics span Europe, Asia, Australia, and North America. In Australia, RHDV2 drives current wild and domestic losses. US detections surged post-2021, affecting multiple states and species.
WOAH monitors global status, emphasizing trade restrictions and surveillance in leporid populations.
Impact on Pet Owners and Commercial Operations
Pet rabbits in suburban settings face risks from feral populations or shared spaces. Breeders and show enthusiasts encounter heightened exposure, demanding rigorous protocols. Economic losses in meat production highlight vaccination’s role in sustainability.
Frequently Asked Questions (FAQs)
Is Rabbit Calicivirus transmissible to humans?
No, RHDV does not infect humans or other mammals outside lagomorphs.
Can indoor rabbits contract RHDV?
Yes, via contaminated clothing, equipment, or vectors; no environment is risk-free without vaccination.
What is the survival time of the virus outside a host?
Up to 3-7 months in dry conditions, longer in cool, moist environments.
When should I vaccinate my rabbit kits?
From 4 weeks for RHDV2 coverage; consult vets for schedules.
Does recovery confer lifelong immunity?
Subacute survivors develop antibodies, but boosters ensure protection against variants.
Emerging Research and Future Outlook
Ongoing studies explore multivalent vaccines covering all strains and potential gene therapies. Surveillance enhances early detection, curbing outbreaks. Owners play a pivotal role by reporting suspicions to authorities.
References
- Rabbit Haemorrhagic Disease Virus (Calicivirus) – DAFF — Australian Department of Agriculture, Fisheries and Forestry. 2023. https://www.agriculture.gov.au/agriculture-land/animal/health/rabbit-haemorrhagic-disease-virus
- Rabbit haemorrhagic disease (RHD) and rabbit calicivirus disease — PMC (NCBI). 2012-04-26. https://pmc.ncbi.nlm.nih.gov/articles/PMC3331820/
- Infectious Diseases in Rabbits | VCA Animal Hospitals — VCA Hospitals. 2023. https://vcahospitals.com/know-your-pet/rabbits-diseases
- Rabbit haemorrhagic disease – World Organisation for Animal Health — WOAH. 2023. https://www.woah.org/en/disease/rabbit-haemorrhagic-disease/
- Rabbit Hemorrhagic Disease | Utah Department of Agriculture — Utah Dept. of Agriculture. 2023. https://ag.utah.gov/animal-industry/animal-health-program/rabbit-hemorrhagic-disease/
- Rabbit Hemorrhagic Disease – USDA APHIS — USDA APHIS. 2023. https://www.aphis.usda.gov/livestock-poultry-disease/rabbit-hemorrhagic
Similar Articles
Read full bio of Sneha Tete